EUVIMEDEUVIMED entdecken
Crossref

Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology

Toshiki Miwa, Koh Okamoto, Yoshimi Higurashi, Keiko Soneda, Shinya Yamamoto, Akihiko Ichida, Nobuhisa Akamatsu, Kiyoshi Hasegawa, Takeya Tsutsumi

Transplantation Proceedings · 2026

DOI: 10.1016/j.transproceed.2026.07.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Toshiki Miwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Liver Transplantation, Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Nontuberculous mycobacteria (NTM) disease is a significant morbidity in solid organ transplant recipients. Its management needs to be individualized based on factors including the potential drug-related adverse effects, which is a particular concern for liver transplant (LTx) recipients. We aim to investigate the incidence proportion, clinical presentation, management, and outcome of NTM isolation and NTM diseases in our LTx recipients. METHODS: We conducted a single-center retrospective study in Japan. We included all LTx recipients with age ≥ 18 who had posttransplant mycobacterial microbiological testing of any clinical specimens between April 2005 and March 2022. Participants with NTM isolation who satisfied the diagnostic criteria in American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) guidelines were defined as having NTM diseases. We collected demographic, clinical, microbiological, and radiographic data of participants through chart reviews. RESULTS: Of all 472 LTx recipients, 115 received at least one mycobacterial microbiological test, of whom 15 had positive test results. Six participants had an NTM disease, all of which were pulmonary infections (6/472: 1.3%). None of them received treatment for NTM diseases, even when alternative diagnoses were absent. Except for one patient who died of posttransplant lymphoproliferative disorder, five remained free of exacerbation of NTM disease and were alive at the end of the study period, with 1067-4825 days of follow-up periods. CONCLUSIONS: Late-onset pulmonary NTM diseases meeting ATS/IDSA criteria may be safely observed without treatment in selected LTx recipients. Diagnostic criteria may need to be tailored for immunocompromised patients including LTx recipients to help guide the management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationMycobacterium Infections, NontuberculousNontuberculous MycobacteriaHumansFemaleRetrospective StudiesMiddle AgedJapanMaleAdultAgedIncidence

Autor:innen und Institutionen

  • Department of Infectious Diseases, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
  • Department of Infectious Diseases, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan; Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Bunkyo-ku, Tok…
  • Department of Infection Control and Prevention, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
  • Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Department of Infectious Diseases, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan; Department of Infection Control and Prevention, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Miwa, T., Okamoto, K., Higurashi, Y., Soneda, K., Yamamoto, S., Ichida, A., Akamatsu, N., Hasegawa, K., & Tsutsumi, T. (2026). Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.07.023

Vancouver

Miwa T, Okamoto K, Higurashi Y, Soneda K, Yamamoto S, Ichida A, et al. Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.07.023

BibTeX
@article{Miwa2026,
  author = {Miwa, Toshiki and Okamoto, Koh and Higurashi, Yoshimi and Soneda, Keiko and Yamamoto, Shinya and Ichida, Akihiko and Akamatsu, Nobuhisa and Hasegawa, Kiyoshi and Tsutsumi, Takeya},
  title = {Significance of Nontuberculous Mycobacteria Detection in Liver Transplant Recipients: A Descriptive Epidemiology},
  journal = {Transplantation Proceedings},
  year = {2026},
  doi = {10.1016/j.transproceed.2026.07.023}
}
Kostenlos starten →